Health Care & Life Sciences » Pharmaceuticals | Enseval Putera Megatrading

Enseval Putera Megatrading | Cash Flow

Fiscal year is January-December. All values IDR Millions.
2013
2014
2015
2016
2017
2018
Funds from Operations
149,437
526,975
640,846
290,932
172,575
582,272
Net Operating Cash Flow
149,437
526,975
640,846
290,932
172,575
582,272
Capital Expenditures
272,099
215,141
180,748
96,520
199,064
Sale of Fixed Assets & Businesses
24,773
36,196
12,048
7,956
20,671
Purchase/Sale of Investments
28,299
26,513
67,400
50
-
Net Investing Cash Flow
275,625
205,458
236,101
88,614
178,393
Cash Dividends Paid - Total
5,417
-
13,543
13,543
13,543
Issuance/Reduction of Debt, Net
17,325
24,860
1,117
89,801
-
Net Financing Cash Flow
11,908
24,860
14,661
103,344
13,543
Net Change in Cash
410,489
295,887
393,022
98,292
364,034
Free Cash Flow
414,381
312,378
460,764
194,471
368,948
Exchange Rate Effect
2,665
771
2,937
682
477

About Enseval Putera Megatrading

View Profile
Address
Jalan Pulo Lentut No. 10
Jakarta JK 13920
Indonesia
Employees -
Website http://www.enseval.com
Updated 07/08/2019
PT Enseval Putera Megatrading Tbk consumer products, medical equipment, cosmetics, and other trading products. It operates through the following segments: Pharmaceutical, Consumer Products, and Others. The company was founded in October 1973 and is headquartered in Jakarta, Indonesia.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.